Rosecliff Acquisition Corp I Cl A (RCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RCLF | TMO | ISRG | EW | DXCM |
| Company | Rosecliff Acquisition Corp I Cl A | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 12.19 | 600.00 | 387.22 | 87.23 | 126.58 |
| High | 13.00 | 602.00 | 399.66 | 90.37 | 130.22 |
| Low | 9.91 | 595.03 | 386.00 | 86.79 | 126.00 |
| Last | 11.57 | 599.02 | 399.39 | 90.16 | 129.71 |
| Change | -0.64 | +4.22 | +15.20 | +3.70 | +3.74 |
| % Change | -5.24% | +0.71% | +3.96% | +4.28% | +2.97% |
| Volume | 150,200 | 1,188,700 | 1,200,700 | 3,111,200 | 2,306,900 |
| 20-Day Average Volume | 269,060 | 1,496,995 | 1,324,950 | 2,845,460 | 2,695,175 |
| Previous Close | 12.21 | 594.80 | 384.19 | 86.46 | 125.97 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.22 | 573.59 | 378.63 | 86.34 | 129.39 |
| 20-Day Raw Stochastic | 24.76% | 95.88% | 99.24% | 96.94% | 41.05% |
| 20-Day Relative Strength | 52.83% | 62.53% | 59.98% | 55.59% | 49.31% |
| Weighted Alpha | +2.10 | +18.24 | +32.67 | +10.39 | +15.68 |
| Today's Opinion | 96% Buy | 88% Buy | 80% Buy | 80% Buy | 56% Buy |
| Previous Opinion | 96% Buy | 88% Buy | 56% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 80% Buy | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.63% since 09/01/23 | +4.42% since 05/08/24 | +5.00% since 05/08/24 | +5.96% since 05/08/24 | +1.80% since 05/08/24 |
| Low | 9.91 on 09/11/23 | 572.50 on 05/09/24 | 379.67 on 05/14/24 | 84.67 on 05/13/24 | 124.25 on 05/14/24 |
| High | 19.50 on 09/07/23 | 602.00 on 05/15/24 | 399.66 on 05/15/24 | 90.37 on 05/15/24 | 130.48 on 05/09/24 |
| 1-Month | |||||
| %Chg | +9.05% since 08/11/23 | +7.38% since 04/15/24 | +5.84% since 04/15/24 | +1.08% since 04/15/24 | -3.60% since 04/15/24 |
| Low | 8.96 on 08/30/23 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 19.50 on 09/07/23 | 602.00 on 05/15/24 | 399.66 on 05/15/24 | 90.40 on 04/16/24 | 139.24 on 04/25/24 |
| 3-Month | |||||
| %Chg | +10.66% since 06/09/23 | +9.20% since 02/15/24 | +5.06% since 02/15/24 | +4.79% since 02/15/24 | +10.21% since 02/15/24 |
| Low | 8.96 on 08/30/23 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 113.05 on 02/28/24 |
| High | 19.50 on 09/07/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | +14.33% since 03/09/23 | +27.30% since 11/15/23 | +36.21% since 11/15/23 | +34.55% since 11/15/23 | +27.03% since 11/15/23 |
| Low | 8.96 on 08/30/23 | 464.17 on 11/17/23 | 295.02 on 11/16/23 | 65.12 on 11/28/23 | 102.00 on 11/16/23 |
| High | 19.50 on 09/07/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 78,487 | 228,655,520 | 141,663,648 | 54,330,416 | 51,583,596 |
| Shares Outstanding, K | 6,784 | 381,716 | 354,700 | 602,600 | 397,684 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | 11,040,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 921,000,000 |
| Last Quarter Net Income | -1,030,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 146,400,000 |
| 60-Month Beta | 0.02 | 0.80 | 1.39 | 1.10 | 1.23 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | N/A | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.51 | 82.09 | 33.91 | 75.89 |